SepMate™-50 (IVD)
STEMCELL Technologies Inc.Tube for density gradient centrifugation for in vitro diagnostic (IVD) applications
Tube for density gradient centrifugation for in vitro diagnostic (IVD) applications
Optimized biopreservation reagent for hematopoietic cells and tissues
Animal component-free, defined cryopreservation medium with 10% DMSO
Animal component-free, defined cryopreservation medium with 2% DMSO
Animal component-free, defined cryopreservation medium with 5% DMSO
Animal component-free medium for cryopreserving ES and iPS cells as single cells
Animal component-free, defined hypothermic (2 - 8°C) preservation medium for a range of cell and tissue types
Animal component-free MSC cryopreservation medium
Medium for cryopreserving hPSC-derived cardiomyocytes
For cryopreservation of neural progenitor cells generated using STEMdiff™ Neural Induction Medium
3 Channel Microarray Analyzer - Designed for Routine Diagnostics
Detection and Analysis of Multiplexed Microarrays - OEM customized solution
Premium digital microscope for live imaging, scanning and real-time diagnostics of multiple slides
LINE repetitive element methylation assays for human, mouse, rat, or monkey.
Save time automating manual capping and decapping processes in your lab with the Scinomix RapidCAP2 benchtop system.The RapidCAP2 is compatible with a range of 0.5 mL to 2.0 mL inexpensive bulk cryovials.
Supel™ Swift HLB is a polymeric stationary phase for solid phase extraction (SPE) prior to instrumental analysis. It has both hydrophilic and lipophilic functional groups for the extraction of a broad range of compounds from aqueous samples. It retains analytes having diff erent polarities and Log P values due to its hydrophilic and lipophilic balance (HLB) property.
Platelia SARS-CoV-2 Total Ab Assay. Detection of IgM, IgA and IgG in One Test.
CE-marked Enzyme Immunoassay (ELISA) kits for the detection of IgG and IgM antibodies to SARS-CoV-2 in human serum
The COVID-19 ImmunoRank™ Neutralization MICRO-ELISA test for detection of circulating SARS-CoV-2 neutralizing antibodies. The assay is designed to detect antibodies of all Ig classes in human plasma or serum that bind to the SARS-CoV-2 receptor binding domain (RBD) and are capable of blocking the binding of the RBD to angiotensin-converting enzyme 2 (ACE2), the viral entry receptor on the surface of target cells.